SEC Form 4 · accession 0001140361-18-025549
STRATA Skin Sciences, Inc. · SSKN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dolev Rafaeli
Officer — CEO · Director
Period of report
May 23, 2018
Accepted (ET)
May 24, 2018 · 5:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001051514
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| STRATA Stock Options (right to buy)F1 | $1.66 | May 23, 2018 | A | 1,413,249 | A | — | May 23, 2028 | Common Stock | 1,413,249 | 1,413,249 | D |
Explanation of responses
- F1The Options shall be exercisable in twelve equal quarterly installments commencing on August 23, 2018 and continuing through May 23, 2020.